Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BE.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BE.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BE.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BE.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
XBB.2.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
XBB.2.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
FL.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GD.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GD.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GD.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GD.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GD.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GD.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GD.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GA.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GA.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used